Echocardiogram: The Ultrasound Window Into Your Heart

An echocardiogram — an “echo” for short — is an ultrasound of the heart. A technologist (sonographer) presses a small probe against your chest, and sound waves far above the range of human hearing bounce off your heart muscle, valves, and blood. From those returning echoes, a computer builds a live moving picture: your heart beating, in real time, on a screen. It is the same harmless technology used to look at babies during pregnancy. There is no radiation, no needle, and no contrast dye in a standard echo, and it can be repeated as often as needed without accumulating any risk.

That safety is one reason the echocardiogram is the workhorse of cardiology. But the bigger reason is what it shows. Blood tests like troponin tell you whether heart muscle is being damaged right now; a coronary calcium score tells you how much plaque has built up in the arteries over decades. The echo answers a different, equally important set of questions: How well is the heart actually pumping? Are the valves opening and closing properly? Are the chambers the right size? Is the pressure in the lungs normal? If your doctor has ordered one — or you are holding a report full of unfamiliar abbreviations like EF, LVIDd, and E/e′ — this page walks through what the test is, what the numbers mean, and what an echo can and cannot tell you.

What an Echocardiogram Is
The Four Main Types
What It Measures
When Doctors Order One
How to Read Your Report
What It Cannot See
Preparation & What the Test Is Like
Costs and Access
Lifestyle & Nutrition Connections
Research Papers
Connections
Featured Videos

What an Echocardiogram Is

The standard test is the transthoracic echocardiogram (TTE) — “trans-thoracic” simply means “through the chest.” The probe (transducer) sends pulses of high-frequency sound into the chest and listens for the echoes that bounce back from each layer of tissue. Because sound reflects differently off muscle, valve tissue, and blood, the machine can reconstruct a detailed cross-section of the beating heart many times per second.

Modern echo machines add two more tricks. Doppler imaging measures the speed and direction of blood flow — the same physics that makes an ambulance siren change pitch as it passes you. This is how an echo can tell that blood is leaking backward through a valve, or being forced through a narrowed one at abnormally high speed. Color Doppler paints those flows in red and blue on the screen, so a leak literally shows up as a colored jet. The technique dates to the early 1950s, when Inge Edler and Carl Hellmuth Hertz in Lund, Sweden first recorded moving echoes from a living heart, and it has been refined continuously ever since.

The result is a test that is painless, radiation-free, takes under an hour, and gives a cardiologist an enormous amount of information — often enough to make or rule out a diagnosis on the spot. To see the anatomy the echo is looking at in motion, the site's interactive animation How Your Heart Pumps Blood shows the chambers, valves, and flow pattern the sonographer is tracing on screen.

The Four Main Types

“Echocardiogram” is a family of tests. The four you are most likely to encounter:

Transthoracic echo (TTE) — the standard test described above, done through the chest wall with gel and a probe. No preparation, no sedation, no recovery time. This is what “an echo” means unless someone says otherwise.
Transesophageal echo (TEE) — a much smaller probe on a flexible tube is passed down the esophagus (food pipe), which sits directly behind the heart. Because the sound waves no longer have to cross ribs and lung, the images are far sharper. Doctors order a TEE when they need close-up detail: looking for blood clots in the left atrial appendage before a rhythm procedure, examining a valve for infection (endocarditis), or evaluating an artificial valve. You are sedated, and your throat is numbed. It is more involved than a TTE, but serious complications such as esophageal injury are rare.
Stress echocardiogram — images are taken at rest and again immediately after your heart rate is pushed up, either by walking on a treadmill or, if you cannot exercise, by an infusion of a medication such as dobutamine that makes the heart beat harder. The logic: a region of heart muscle fed by a severely narrowed artery may move normally at rest but weaken visibly under stress. A stress echo is one of the standard ways to look for functionally significant coronary artery disease without a catheter.
Bubble study (agitated saline contrast) — sterile salt water is shaken into tiny bubbles and injected into an arm vein during the echo. The bubbles light up the right side of the heart; if any cross immediately to the left side, there is a hole or channel that should not be there — most often a patent foramen ovale (PFO), a leftover flap from fetal circulation present in roughly one in four adults. Bubble studies are common after an unexplained stroke, especially in younger people.

You may also see ultrasound enhancing agents (echo contrast) mentioned on a report. These are microbubble solutions used when the standard images are technically difficult — they fill the left ventricle brightly so its borders can be traced accurately. They are not iodinated CT dye and do not affect the kidneys.

What It Measures

An echo report is long because the test measures many independent things. The major categories, in plain language:

Ejection fraction (EF) — the headline number. With each beat, the left ventricle squeezes out some — never all — of the blood it holds. The percentage ejected per beat is the ejection fraction. A common misreading is to hear “EF 60%” and worry that 40% of your blood is stuck. In fact, a completely healthy heart ejects only about half to two-thirds of its contents on every beat; the rest is the reserve it draws on when you exert yourself. The normal range most labs quote is 50–70% (the American Society of Echocardiography's chamber-quantification guideline gives approximately 52–72% for men and 54–74% for women). An EF of 40–49% is mildly-to-moderately reduced territory, and an EF of 40% or below defines heart failure with reduced ejection fraction (HFrEF) when symptoms are present. Crucially, you can have real heart failure with a normal EF — HFpEF (heart failure with preserved ejection fraction) — when the ventricle squeezes fine but has become too stiff to fill properly. That is why the rest of the report matters as much as the EF.

Chamber sizes. The echo measures the dimensions and volumes of all four chambers. A dilated (enlarged) left ventricle can indicate cardiomyopathy or a chronically leaking valve; an enlarged left atrium is a footprint of years of elevated filling pressure and is closely tied to atrial fibrillation risk; an enlarged right ventricle raises questions about lung disease, clots, or shunts. Thickened ventricular walls (hypertrophy) most often reflect long-standing high blood pressure, though genetic hypertrophic cardiomyopathy and infiltrative diseases like amyloidosis are also on the list.

Wall motion. The heart's muscular wall is assessed segment by segment. After a heart attack, the scarred territory moves weakly (hypokinesis), not at all (akinesis), or bulges paradoxically outward (dyskinesis). The pattern of weak segments maps onto which coronary artery was involved.

Valve function. Each of the four valves is checked for two opposite problems. Stenosis means the valve has become stiff and narrow and will not open fully, so the heart must generate high pressure to push blood through — the Doppler measures that jet's velocity and pressure gradient directly. Regurgitation means the valve does not close tightly and blood leaks backward. Both are graded, typically as mild, moderate, or severe (stenosis grading also uses measured valve area and gradients — for example, severe aortic stenosis is conventionally defined by a valve area below about 1.0 cm² or a mean gradient of 40 mmHg or more). One reassurance worth stating plainly: “trace” or “trivial” regurgitation is found in a large share of completely healthy hearts and is generally a normal finding, not a disease.

Diastolic function. Squeezing is only half the job; the ventricle must also relax and refill between beats. Doppler measurements of filling patterns (graded roughly I through III as dysfunction worsens) estimate how stiff the ventricle is and how high the pressure inside it runs. This is the part of the echo that detects the physiology behind HFpEF.

Pulmonary pressures. By measuring the velocity of the small backward leak across the tricuspid valve that most people have, the echo can estimate the pressure in the pulmonary artery. Elevated estimates raise the question of pulmonary hypertension — from left-heart disease, lung disease, sleep apnea, or blood clots — and may prompt confirmation by right heart catheterization, since the echo value is an estimate, not a direct measurement.

The pericardium and everything else. The echo also sees fluid around the heart (pericardial effusion), clots or masses inside the chambers, congenital abnormalities, and the first portion of the aorta.

When Doctors Order One

Common, well-established reasons an echocardiogram gets ordered:

A heart murmur. A murmur is just a sound — turbulent blood flow heard through a stethoscope. Many are innocent, especially in young people; the echo settles whether a real valve problem is behind it and, if so, how severe.
Shortness of breath (dyspnea), swelling, or fatigue. The echo separates cardiac causes — weak pumping, stiff filling, valve disease, pericardial fluid — from lung and other causes, usually alongside a BNP / NT-proBNP blood test.
Fainting (syncope) or palpitations, to look for structural causes such as aortic stenosis, hypertrophic cardiomyopathy, or a weak ventricle that predisposes to dangerous rhythms.
During and after a heart attack. The echo shows how much muscle was stunned or scarred, tracks EF recovery, and screens for mechanical complications. The EF measured weeks later drives major decisions — an EF that remains at or below 35% despite good medical therapy is the conventional threshold for discussing a defibrillator (ICD).
Chemotherapy monitoring. Several cancer drugs — anthracyclines such as doxorubicin, and HER2-targeted agents such as trastuzumab — can weaken the heart muscle. A baseline echo followed by scheduled re-checks (often including a sensitive strain measurement called GLS) catches early decline while it is still reversible or treatable.
High blood pressure, to look for the end-organ consequences: thickened walls (LVH), a stiffening ventricle, and a dilating left atrium.
Atrial fibrillation, stroke, suspected endocarditis, pulmonary hypertension, congenital disease, and valve follow-up — each with its own protocol, sometimes requiring the TEE close-up rather than a standard TTE.

How to Read Your Report

Echo reports are written by cardiologists for other clinicians, so they arrive dense with abbreviations. Here is a translation table for the terms patients ask about most:

EF or LVEF — left ventricular ejection fraction, discussed above. 50–70% is the commonly quoted normal band. Reports may give a single number (“EF 60%”) or a range (“55–60%”); a visually estimated range is normal practice, not sloppiness.
LVIDd / LVIDs — the left ventricle's internal diameter in diastole (filled) and systole (squeezed), in centimeters or millimeters. For LVIDd, roughly 4.2–5.8 cm in men and 3.8–5.2 cm in women is the guideline normal range; larger suggests dilation. Body size matters, which is why reports often “index” measurements to body surface area.
IVSd and LVPWd — the thickness of the septum (the wall between the ventricles) and the posterior wall. Values much above about 1.1 cm suggest hypertrophy, most often from blood pressure.
LA volume index (LAVi) — left atrial size adjusted for body size; values above 34 mL/m² are considered enlarged and hint at chronically elevated filling pressures.
E/e′ (“E over e-prime”) — the workhorse estimate of left ventricular filling pressure, comparing the speed of early blood inflow (E) to the speed of the relaxing muscle itself (e′). An average E/e′ below about 8 is reassuring; values above about 14 suggest the ventricle is filling under high pressure — a core finding in HFpEF.
TAPSE — a simple measure of right ventricular squeeze (how far the tricuspid valve ring moves toward the apex). Values below about 1.7 cm (some labs use 1.6) suggest reduced right-ventricular function.
RVSP or PASP — the estimated pulmonary artery pressure described above. Many labs flag estimates in the mid-30s (mmHg) or higher for correlation with the clinical picture.
Valve grades — each valve gets a stenosis and/or regurgitation grade: none/trace/mild/moderate/severe. Remember that trace and mild regurgitation of the mitral, tricuspid, and pulmonic valves are extremely common in healthy people.
“Aortic sclerosis” — thickening/calcification of the aortic valve without obstruction. Common with age; it is a reason for periodic follow-up, not a diagnosis of stenosis.
GLS (global longitudinal strain) — a newer, more sensitive measure of muscle deformation, reported as a negative percentage (more negative is better; many labs treat values weaker than about −18% as borderline). Used especially in chemotherapy monitoring to catch decline before the EF falls.
“Technically difficult/limited study” or “suboptimal windows” — the sound waves had trouble getting through (body habitus, lung disease, rib spacing). It is a statement about image quality, not about your heart, and it is why contrast agents or a repeat study sometimes follow.

Two pieces of perspective. First, single measurements have error bars: an EF read as 55% today and 60% next year has not necessarily changed at all — that difference is within the test's normal variability. Trends across multiple studies mean far more than small one-time shifts. Second, no single line of the report is a verdict. Cardiologists read the whole pattern — a mildly abnormal number in isolation, in a person with no symptoms, frequently warrants nothing more than routine follow-up. Take the report as a whole to the doctor who ordered it before drawing conclusions from any one row.

What It Cannot See

Here is the limitation that surprises people most: a standard echocardiogram does not visualize the coronary arteries — the small vessels on the heart's surface whose blockage causes heart attacks. They are simply too small and too fast-moving for surface ultrasound to image directly. An echo sees the consequences of coronary disease once muscle is damaged or stressed (wall-motion abnormalities), but it cannot count plaques or measure blockages.

The practical consequence: a normal echocardiogram does not rule out coronary artery disease. You can have extensive plaque, even critical narrowings, with a resting echo that looks pristine — because at rest, with no prior heart attack, the pump and valves may still work perfectly. People are sometimes told “your echo was normal” and understandably hear “my arteries are clear.” The test never looked at the arteries.

Different questions need different tests, and they complement rather than replace each other:

Echocardiogram — pump function, valves, chamber sizes, pressures. The mechanics.
Coronary calcium score (CAC) — a quick CT that quantifies calcified plaque burden in the artery walls. The decades-long risk picture.
CT or invasive coronary angiography — contrast imaging of the artery channels themselves, showing exactly where and how severe any blockages are. The plumbing map.
Troponin — the blood marker of active heart-muscle injury. The right-now damage signal.

A stress echo partially bridges the gap — it infers a flow-limiting blockage from how the muscle behaves under load — but anatomy still requires CT or catheter angiography. If your concern is silent plaque rather than symptoms, the calcium score is the inexpensive screening complement to a normal echo.

Preparation & What the Test Is Like

For a standard TTE: no preparation at all. Eat normally, take your medications, wear a two-piece outfit for practicality (you undress from the waist up and wear a gown). In the room, a sonographer places a few EKG stickers on your chest, dims the lights, and applies warm gel to the probe. You lie mostly on your left side while the probe is pressed at several spots on the chest and upper abdomen; firm pressure is normal and occasionally briefly uncomfortable, but not painful. You will hear whooshing sounds when Doppler is on — that is your own blood flow, made audible. You may be asked to hold your breath for a few seconds at a time. Plan on 30–45 minutes, sometimes up to an hour if measurements are extensive. You drive yourself home and resume everything immediately. A cardiologist reviews the images afterward, so results typically arrive in a few days through your doctor or patient portal rather than in the room.

For a TEE: because of sedation, the rules change — typically no food for about 6 hours beforehand (your scheduling instructions govern), a numbing spray to the throat, an IV sedative that makes most people drowsy or lightly asleep, and a probe passed down the esophagus for a procedure that usually takes 10–20 minutes once started. Plan for a few hours at the facility in total, arrange a ride home, and expect a mildly sore throat for a day. Tell the team about swallowing problems or esophageal disease in advance.

For a stress echo: wear shoes you can walk briskly in; you may be told to hold certain heart-rate-slowing medications (such as beta-blockers) beforehand — only on the ordering doctor's instruction. Caffeine guidance varies by lab. The whole appointment typically runs about an hour.

Costs and Access

Echocardiography pricing in the United States is notoriously variable, and the ranges below are approximate. Cash prices for a standard TTE commonly run from roughly $200–$500 at independent imaging centers and some cardiology offices to $1,000–$3,000 or more at hospital outpatient departments — the same test, read by similarly qualified cardiologists. If you are paying out of pocket, it is entirely reasonable to ask for the cash price in advance and to compare a freestanding imaging center against the hospital; the difference frequently exceeds a thousand dollars. TEE and stress echo cost more because they involve physicians, sedation or monitoring, and more staff time.

Insurance and Medicare generally cover echocardiograms that are medically indicated — ordered for symptoms, a murmur, follow-up of known disease, or drug monitoring — subject to your deductible and coinsurance. What is typically not covered is screening of a healthy, symptom-free person with a normal exam, because major guidelines do not recommend routine echo screening in the general population. If cost is a barrier, ask about self-pay discounts, hospital financial-assistance policies, and itemized bills; billing errors in imaging are common enough that reviewing the itemization is worth ten minutes.

Lifestyle & Nutrition Connections

Several of this site's core topics show up directly, and honestly, in echo findings:

Blood pressure and left ventricular hypertrophy. Years of uncontrolled hypertension literally reshape the heart: the walls thicken (LVH), the ventricle stiffens, and the left atrium dilates — the echo watches this sequence happen, and it is the on-ramp to HFpEF and atrial fibrillation. The encouraging half of the story is equally visible: sustained blood-pressure control (medication, sodium reduction, weight loss, exercise) can partially regress hypertrophy on follow-up echoes over months to years.
Omega-3 fatty acids and heart function. The evidence here deserves honest sizing: in established heart failure, the large GISSI-HF trial found a modest reduction in mortality and hospitalization with 1 g/day of omega-3s — real but small, a complement to (never a substitute for) guideline heart-failure medications. Omega-3s more reliably lower triglycerides and are reasonably obtained from food first — see Omega-3 Fatty Acids for sources and dosing context.
Alcohol and cardiomyopathy. Sustained heavy drinking is a well-documented cause of dilated cardiomyopathy — an enlarged, weakly squeezing ventricle with reduced EF on echo. The direction of the finding matters to anyone holding such a report: with genuine abstinence and modern heart-failure therapy, alcohol-related cardiomyopathy is among the more recoverable forms, and serial echoes often document meaningful EF improvement. Continued drinking predicts the opposite course.
Thiamine (vitamin B1) and heart failure. Severe thiamine deficiency causes wet beriberi — a high-output form of heart failure that improves dramatically with thiamine replacement; it remains under-recognized in people with alcohol overuse, malnutrition, or after bariatric surgery. Separately, loop diuretics such as furosemide — a mainstay of congestive heart failure treatment — increase urinary thiamine losses, and small studies have found low thiamine status in a meaningful fraction of heart-failure patients. Supplementation trials to date are small and mixed, so the fair summary is: thiamine deficiency is a correctable contributor worth ruling out in the right context, not a general heart-failure therapy. Background at Vitamin B1 (Thiamine).
Weight, sleep apnea, and the right heart. Untreated obstructive sleep apnea shows up on echo as elevated pulmonary-pressure estimates and right-heart strain — one more reason a snoring, exhausted patient with borderline RVSP deserves a sleep study.

None of these replace the medication decisions an abnormal echo may trigger — but they are the levers a patient personally controls, and repeat echocardiograms are how their effect becomes visible.

Research Papers and References

The documents below are the standards cardiologists and sonographers actually use — the guideline papers that define the normal ranges, grading scales, and protocols quoted on this page. Each citation links to the full text via DOI.

Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2015;28(1):1–39.e14. — the source of the normal ranges for EF, chamber dimensions, and wall thickness.
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2016;29(4):277–314. — the E/e′ and diastolic-grading framework.
Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2019;32(1):1–64. — what a complete TTE protocol includes.
Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation. Journal of the American Society of Echocardiography. 2017;30(4):303–371. — how regurgitation severity grades are assigned.
Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2010;23(7):685–713. — TAPSE and right-heart measurements.
Hahn RT, Abraham T, Adams MS, et al. Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Journal of the American Society of Echocardiography. 2013;26(9):921–964. — the TEE protocol.
Pellikka PA, Arruda-Olson A, Chaudhry FA, et al. Guidelines for Performance, Interpretation, and Application of Stress Echocardiography in Ischemic Heart Disease: From the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2020;33(1):1–41.e8. — stress echo methodology and indications.
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation. 2022;145(18):e895–e1032. — the HFrEF / HFpEF ejection-fraction definitions and treatment framework.

Live PubMed Searches

Live PubMed queries that update as new papers are indexed.

External Authoritative Resources

Back to Table of Contents

Connections